English | Español
Patient Daily | Jan 14, 2026

Calls grow for stronger federal action as US risks losing edge in biotechnology
Patient Daily | Jan 13, 2026

Biotech investors predict active dealmaking and broader focus for 2026
Patient Daily | Jan 13, 2026

Analysts anticipate rebound for biopharma venture capital after late-2025 surge
Patient Daily | Jan 13, 2026

FDA rejects Vanda’s bid for Hetlioz approval in treating jet lag
Patient Daily | Jan 13, 2026

Eli Lilly acquires Ventyx Biosciences for $1.2B; announces cancer therapy pact with InduPro
Patient Daily | Jan 13, 2026

Parabilis secures $305M to advance cancer drug amid biotech fundraising surge
Patient Daily | Jan 13, 2026

Penn researchers develop gene therapy aimed at non-addictive chronic pain relief
Patient Daily | Jan 13, 2026

TU Graz researchers find espresso effective for electron microscopy staining

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Regulatory
A. D. Brady | Mar 30, 2026

Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Alliance for Consumers releases update on trial law firm political donations
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026